Business Description
Flerie AB
ISIN : SE0022447348
Compare
Compare
Traded in other countries / regions
FLERIE.Sweden1NP1.Germany IPO Date
2016-10-11Description
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1012.56 | |||||
| Equity-to-Asset | 0.99 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 79.18 | |||||
| Beneish M-Score | 101209.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 968.6 | |||||
| 3-Year EBITDA Growth Rate | 9.4 | |||||
| 3-Year EPS without NRI Growth Rate | 9.1 | |||||
| 3-Year FCF Growth Rate | 38.2 | |||||
| 3-Year Book Growth Rate | 29.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.92 | |||||
| 9-Day RSI | 75.61 | |||||
| 14-Day RSI | 67.85 | |||||
| 6-1 Month Momentum % | 20.43 | |||||
| 12-1 Month Momentum % | -44.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 45.89 | |||||
| Quick Ratio | 45.89 | |||||
| Cash Ratio | 39.28 | |||||
| Days Sales Outstanding | 2.36 | |||||
| Days Payable | 59.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -31 | |||||
| Shareholder Yield % | -17.13 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 8.81 | |||||
| Operating Margin % | -172.08 | |||||
| Net Margin % | 173.95 | |||||
| FCF Margin % | -28.83 | |||||
| ROE % | 9.97 | |||||
| ROA % | 9.75 | |||||
| ROIC % | -12.77 | |||||
| 3-Year ROIIC % | -113.02 | |||||
| ROC (Joel Greenblatt) % | 13653.19 | |||||
| ROCE % | 15.45 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 1.2 | |||||
| PE Ratio without NRI | 1.23 | |||||
| Price-to-Owner-Earnings | 15.75 | |||||
| PEG Ratio | 0.16 | |||||
| PS Ratio | 2.23 | |||||
| PB Ratio | 0.83 | |||||
| Price-to-Tangible-Book | 0.83 | |||||
| EV-to-EBIT | 8.89 | |||||
| EV-to-EBITDA | 8.85 | |||||
| EV-to-Revenue | 24 | |||||
| EV-to-FCF | -83.99 | |||||
| Price-to-Projected-FCF | 1.28 | |||||
| Price-to-Graham-Number | 0.21 | |||||
| Price-to-Net-Current-Asset-Value | 3.41 | |||||
| Price-to-Net-Cash | 4 | |||||
| Earnings Yield (Greenblatt) % | 11.25 | |||||
| FCF Yield % | -0.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Flerie AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 108.439 | ||
| EPS (TTM) (kr) | 37.787 | ||
| Beta | 0 | ||
| Volatility % | 90.49 | ||
| 14-Day RSI | 67.85 | ||
| 14-Day ATR (kr) | 1.19339 | ||
| 20-Day SMA (kr) | 42.78025 | ||
| 12-1 Month Momentum % | -44.74 | ||
| 52-Week Range (kr) | 19.8 - 81.8 | ||
| Shares Outstanding (Mil) | 78.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Flerie AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Flerie AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Flerie AB Frequently Asked Questions
What is Flerie AB(OSTO:FLERIE)'s stock price today?
The current price of OSTO:FLERIE is kr45.00. The 52 week high of OSTO:FLERIE is kr81.80 and 52 week low is kr19.80.
When is next earnings date of Flerie AB(OSTO:FLERIE)?
The next earnings date of Flerie AB(OSTO:FLERIE) is 2024-11-19.
Does Flerie AB(OSTO:FLERIE) pay dividends? If so, how much?
Flerie AB(OSTO:FLERIE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers